These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 364545)

  • 1. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
    Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
    Ubatuba FB; Moncada S; Vane JR
    Thromb Haemost; 1979 Apr; 41(2):425-35. PubMed ID: 382434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some actions of prostacyclin (PGI2) on the cardiovascular system and the gastric microcirculation.
    Whittle BJ; Moncada S; Vane JR
    Acta Biol Med Ger; 1978; 37(5-6):725-8. PubMed ID: 369255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue.
    Whittle BJ; Moncada S; Mullane K; Vane JR
    Prostaglandins; 1983 Feb; 25(2):205-23. PubMed ID: 6344147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin releasing polymers - stability and efficacy.
    McRea JC; Ebert CD; Kim SW
    Trans Am Soc Artif Intern Organs; 1981; 27():511-6. PubMed ID: 7036503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-aggregatory effect of prostacyclin (PGI2) in vivo.
    Bayer BL; Blass KE; Förster W
    Br J Pharmacol; 1979 May; 66(1):10-2. PubMed ID: 378308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
    Wong PY; McGiff JC; Sun FF; Lee WH
    Eur J Pharmacol; 1979 Dec; 60(2-3):245-8. PubMed ID: 393526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease.
    Fitscha P; Kaliman J; Sinzinger H
    Am J Hematol; 1985 May; 19(1):13-9. PubMed ID: 3885723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influences of prostaglandins on electrophoretic mobility and aggregation of rabbit platelets.
    Takano S; Itagaki S; Sakurai K; Suzuki T
    Prostaglandins; 1980 Sep; 20(3):579-86. PubMed ID: 6999547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandins and platelet aggregation.
    Smith JB
    Acta Med Scand Suppl; 1981; 651():91-9. PubMed ID: 7034481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractoriness of diabetic platelets to inhibitory prostaglandins.
    Lagarde M; Berciaud P; Burtin M; Dechavanne M
    Prostaglandins Med; 1981 Oct; 7(4):341-7. PubMed ID: 6273957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins E1 and E2, but neither prostacyclin nor prostaglandin D2 have anti-aggregating activity in chicken blood.
    Bult H; Wechsung E; Houvenaghel A; Herman AG
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):306-8. PubMed ID: 7013724
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostanoids and hemostasis in chickens: anti-aggregating activity of prostaglandins E1 and E2, but not of prostacyclin and prostaglandin D2.
    Bult H; Wechsung E; Houvenaghel A; Herman AG
    Prostaglandins; 1981 Jun; 21(6):1045-58. PubMed ID: 7027319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
    Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets.
    Hamid S; Whittle BJ
    Br J Pharmacol; 1985 May; 85(1):285-90. PubMed ID: 2992652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandins as inhibitors of human platelet aggregation.
    Di Minno G; Silver MJ; de Gaetano G
    Br J Haematol; 1979 Dec; 43(4):637-47. PubMed ID: 393296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective antagonism of prostaglandin (PG) E1, PGD2 and prostacyclin (PGI2) on human and rabbit platelets by di-4-phloretin phosphate (DPP).
    Westwick J; Webb H
    Thromb Res; 1978 Jun; 12(6):973-8. PubMed ID: 358484
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
    Griffiths RJ; Moore PK
    Br J Pharmacol; 1983 Oct; 80(2):395-402. PubMed ID: 6360281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.